Research location
Cheboksary
Russia
Advertisement
Research activity in Cheboksary
RussiaCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Cheboksary
10 linked trials · page 1 of 1A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionNCT05022004 · 2021-12-20 · 1 site observation
COMPLETED
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in RussiaNCT04943497 · 2021-07-27 · 1 site observation
COMPLETED
Heart Failure Patients RegistryNCT04709263 · 2020-12-21 · 1 site observation
COMPLETED
A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian FederationNCT04138199 · 2019-11-01 · 1 site observation
TERMINATED
Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.NCT03703869 · 2018-03-06 · 1 site observation
COMPLETED
A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment IntensificationNCT02906917 · 2016-09-20 · 1 site observation
COMPLETED
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 DiabetesNCT02825251 · 2016-07-06 · 1 site observation
COMPLETED
A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes MellitusNCT02302716 · 2014-12-01 · 1 site observation
COMPLETED
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration AlgorithmsNCT02298192 · 2014-11-21 · 1 site observation
COMPLETED
A Study in Patients With Type 2 Diabetes MellitusNCT01435616 · 2011-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.